Current Protocols Webinars


The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis
December 10, 2015 at 11am-12 pm EST (8-9am PST; 4-5pm GMT; 5-6pm CET)

  • Dr. Max Salfinger, National Jewish Health

Click here to be notified of future Current Protocols webinars

Available On Demand

Current Protocols webinars are available for viewing approximately 2 days after the live event. If you did not pre-register, a very brief, free registration is required. Slides from each presentation are also available for downloading.

Increasing Large-Scale Protein Production Using a Novel Supplement Without Affecting Metabolic Profiles*
Tuesday, November 3, 2015

  • Dr. Adam Elhofy, CSO Essential Pharmaceuticals

The ABCs of ADC (Antibody Drug Conjugate) Characterization*
Wednesday, September 23, 2015

  • Dr. April Xu, Pfizer Biopharmaceutical Science

Simplified Methods for Investigating Deregulation of the Cell Cycle and Apoptosis in Cancer Progression, and the Implications for Anti-Cancer Therapies*
June 23, 2015

  • Dr. Kai Stober, Shionogi Ltd
  • Dr. Kamala Tyagarajan, EMD-Millipore

Overcoming Sample-related Challenges for Elispot and Other Functional T cell Assays To Produce More Reliable Immune Monitoring*
June 10, 2015

  • Sylvia Janetzki, M.D., ZellNet Consulting

Extracellular Vesicle Enrichment and Characterization from Cell Culture Supernatants and Biological Fluids*
May 21, 2015

  • Dr. Aled Clayton, Cardiff University
  • Dr. Amedeo Cappione, III, EMD Millipore

Combining Data-Independent Analysis for Broad-Scale Phenotyping and Targeted Tandem Mass Spectrometry Quantification of Specific Biomarkers*
April 29, 2015

The 14th Annual Wiley Prize in Biomedical Sciences Awarded for DNA Damage Response*
April 17, 2015

  • Evelyn Witkin, Ph.D., Professor Emerita, The Waksman Institute of Microbiology at Rutgers, The State University of New Jersey
  • Stephen Elledge, Ph.D., Professor of Genetics at Harvard Medical School

Antimicrobial Stewardship in Hospitals: A Patient Safety Emergency*
January 20, 2015

  • Dr. Dilip Nathwani, Ninewells Hospital and Medical School, Dundee, UK

Q Exactive HF and LipidSearch – The High Performance Solution for Complex Lipidomics*
November 20, 2014

  • Dr. Reiko Kiyonami, Thermo Fisher Scientific
  • Dr. David Peake, Thermo Fisher Scientific

Measuring Toxicity Biomarkers in Mouse Models and Other Small-volume Samples*
November 4, 2014

  • Dr. Mitch McGill, University of Kansas Medical Center
  • Dr. Venkata Sabbisetti, Harvard Medical School

Neuroinflammation Models: Use in Studies of Neurodegeneration and Regeneration*
October 7, 2014

  • Dr. M. Kerry O'Banion, University of Rochester School of Medicine & Dentistry

Multiplexing Mass Spectrometry-Based Identification and Quantification of Site-Specific Reversible Cysteine Modifications*
September 30, 2014

  • Dr. Kay-Hooi Khoo, Academia Sinica, Taiwan

The Role of GC-MS/MS in Metabolomics Experiments and the Exploration of Optimized Workflows*
June 12, 2014

  • Dr. Vladimir Shulaev, Professor in the Dept. of Biological Sciences at the University of North Texas
  • Dwain Cardona, Senior Application Scientist for the Thermo Fisher Scientific GC Triple Quadrupole Mass Spectrometer applications group

Metabolomic Profiling of Anionic Metabolites in Head and Neck Cancer Cells by Capillary Ion Chromatography with Orbitrap Mass Spectrometry*
April 15, 2014

  • Junhua Wang, Thermo Fisher Scientific

  • A Translational Proteomics Workflow Coupling Immunoenrichment to Selected-Reaction Monitoring (MSIA-SRM) and its Application to Alzheimer's Disease*
    December 10, 2013

  • Dr. Mary Lopez, Director of Biomarker Research Initiatives in Mass Spectrometry (BRIMS) at ThermoFisher Scientific

  • Multiplex Assay Design Fundamentals and Applications in Cancer Research*
    October 23, 2013

  • Brian Haab, Head of the Laboratory of Cancer Immunodiagnostics, Van Andel Research Institute
  • Beatriz M. Carreno, Washington University School of Medicine in St. Louis

  • Stem Cell and Reprogramming Research Methods: Practical Considerations for Studies of Disease Including Culture Methods and Genetic Manipulation*
    October 10, 2013

  • Kevin Eggan, HHMI, Harvard Stem Cell Institute

  • Advances in Quantitative Proteomics: Parallel Reaction Monitoring Applied to Large-scale Studies*
    June 26, 2013

  • Prof. Bruno Domon, Leader of Clinical Proteomics, Luxembourg Clinical Proteomics Center at CRP-Santé

  • LC-MS-based Metabolomics: Workflows, Strategies and Challenges*
    June 19, 2013

  • Dr. Clary Clish, Director of the Metabolite Profiling Platform, Broad Institute - MIT, Harvard

  • Flow Cytometry: Essential Instrument and Experimental Design Considerations*
    June 5, 2013

  • Dr. J. Paul Robinson, SVM Professor of Cytomics and Professor of Biomedical Engineering, Purdue
  • Dr. John P. Nolan, International Society for Advancement of Cytometry President

  • Advances in Protein Detection and Quantitation Methods: Learn the Crucial Differences and Limitations*
    May 16, 2013

  • Dr. Paul Wingfield, Director of NIAMS Protein Expression Lab, NIH
  • Nuno Goncalves, Manager of Novel Biomolecular Detection, EMD Millipore

  • *FREE registration required to view.